Why the study?
Does anterior lumbar interbody fusion (ALIF) compared to transforaminal lumbar interbody fusion (TLIF) improve 30-day perioperative outcomes in adult patients undergoing elective lumbar fusion?
Does anterior lumbar interbody fusion (ALIF) compared to transforaminal lumbar interbody fusion (TLIF) improve 30-day perioperative outcomes in adult patients undergoing elective lumbar fusion?
Both ALIF and TLIF perform comparably for 30-day perioperative outcomes, though they present different specific complication risk profiles.
Answers are grounded in this paper and cite their sources.
ALIF-TLIF trade-offs in 30-day risks support case-by-case selection; Level 5 data leaves optimal approach open for RCTs.
Background: Operative management of lower back pain often necessitates anterior lumbar interbody fusion (ALIF) or transforaminal lumbar interbody fusion (TLIF). Specific pathoanatomic advantages and indications exist for both approaches, and few studies to date have characterized comparative early outcomes. Methods: Adult patients undergoing elective ALIF or TLIF operations were abstracted from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) years 2011–2014. Univariate analyses were performed by surgery cohort for each outcome and adjusted for demographic/clinical variables (age ≥ 65, sex, race, body mass index, American Society of Anesthesiologists physical classification score, functional status, inpatient/outpatient status, smoking, hypertension, Charlson Comorbidity Index) using multivariable regression. Means, standard errors, mean differences (B), odds ratios (ORs), and associated 95% confidence intervals (CIs) are reported. Significance was assessed at P < .05. Results: Of 8263 subjects (ALIF: 4325, TLIF: 3938), ALIF subjects were younger, less obese, less physically impaired, and had significantly lower rates of hypertension, diabetes, coagulopathy, and previous cardiac surgery. On multivariable analysis, ALIF associated with shorter operative time (B = −11.80 minutes, 95% CI [−16.48, −7.12]; P < .001). Transforaminal lumbar interbody fusion was associated with increased incidence of urinary tract infections (UTIs; OR = 1.57, 95% CI [1.10, 2.26]; P = .013) and of blood transfusions (OR = 1.19, 95% CI [1.04, 1.37]; P = .012). Multivariate analysis also demonstrated TLIF associated with shorter hospital length of stay (B = −0.27 days, 95% CI [−0.54, −0.01]; P = .041), and fewer cases of pneumonia (OR = 0.55, 95% CI [0.32, 0.94]; P = .029) and prolonged ventilator dependency (OR = 0.33, 95% CI [0.12, 0.84]; P = .021). Conclusions: Comparatively, ALIF patients experienced decreased operative time and decreased incidence of postoperative UTIs and blood transfusions. Anterior lumbar interbody fusion patients were more likely to suffer postoperative pulmonary complications and longer hospital stays. Our data support the notion that both anterior and transforaminal surgical approaches perform comparably in context of 30-day perioperative outcomes.
No takes yet. Share an insight, caveat, or question.
Upadhyayula et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: